BioCentury
ARTICLE | Company News

Andrx, First Horizon deal

March 7, 2005 8:00 AM UTC

Fortamet posted $4.5 million in sales for the third quarter of 2004, while sales for Altoprev (previously called Altocor) were not broken out. In January, ADRX announced plans to exit the branded pro...